Veronica R. Chiesi Brown
For Release: January 9, 2017
Rochester Regional Brings New Heart Valve Repair to Region
First in area to repair common valve disorder with minimally invasive procedure
ROCHESTER, NY- A new, minimally invasive heart valve repair procedure is now available locally at the Sands-Constellation Heart Institute at Rochester General Hospital.
Rochester Regional Health is the is the first organization in Rochester, New York to implant the MitraClip ®, a device that repairs a disorder called mitral valve regurgitation (the backflow of blood). Once implanted, the MitraClip® improves valve closure and reduces backflow of blood, allowing the heart to pump blood more efficiently, relieving symptoms and improving the patient’s quality of life.
"The MitraClip® is the first of its kind and our team is proud to be the first in Rochester to offer it. Patients who otherwise may not have many options to treat this condition now have access to something that can significantly improve their lives,” said Ronald Kirshner, MD, chief of cardiac services and cardiothoracic surgery for the Rochester Regional Health Sands-Constellation Heart Institute.
The MitraClip® is a non-surgical permanent implant device delivered to the heart through a blood vessel in the groin (femoral vein). The heart continues to beat during the procedure and does not require a heart-lung bypass machine, which is common for open-heart surgery. After the procedure, patients stay in the hospital overnight for observation. They are discharged the next day and can return to full activity.
"The results are instantaneous, and we can see the improvement in heart function immediately during the procedure," added Jeremiah Depta, MD, director of the advanced valvular and structural heart disease program for the Rochester Regional Health Sands-Constellation Heart Institute.
The American College of Cardiology estimates 600,000 individuals have primary or degenerative mitral regurgitation, making it the most common type of heart valve disorder in the United States. Mitral valve regurgitation places additional burden on the heart and lungs. If left untreated, it can cause more serious heart conditions such as heart failure.
Rochester Regional Health is an integrated health services organization serving the people of Western New York, the Finger Lakes and beyond. The system provides care from 150 locations, including five hospitals; more than 100 primary and specialty practices, rehabilitation centers and ambulatory campuses; innovative senior services, facilities and independent housing; a wide range of behavioral health services; and ACM Medical Laboratory, a global leader in patient and clinical trials. Rochester Regional Health, the region’s second-largest employer, was named one of “America’s Best Employers” by Forbes in 2015. Learn more at RochesterRegional.org.
Rochester General Hospital is a 528-bed tertiary care hospital that has been serving the residents of the Rochester region since 1847. The medical staff of more than 1,000 primary care physicians and specialists offers primary medical care and broad range of specialties.
Friday, November 30, 2018
Rochester Regional Health has announced that its wholly-owned subsidiary, ACM Global Laboratories, has hired Brian Wright to lead ACM Global.Read News Article
Thursday, November 29, 2018
For the third time, Rochester General Hospital has received accreditation from the Surgical Review Corp as a Center of Excellence in Minimally Invasive Gynecology (COEMIG).Read News Article